Nitric oxide topical - NB Therapeutics

Drug Profile

Nitric oxide topical - NB Therapeutics

Alternative Names: gNO

Latest Information Update: 02 Jun 2015

Price : $50

At a glance

  • Originator Theranox
  • Developer NB Therapeutics
  • Class Antiacnes; Antiandrogens; Antibacterials; Antihypertensives; Antivirals; Free radicals; Nitrogen oxides; Non-opioid analgesics; Small molecules; Vasodilators
  • Mechanism of Action Free radical scavengers; Nitric oxide stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Chronic wounds
  • Discontinued Leg ulcer; Skin and soft tissue infections; Skin ulcer; Tinea pedis; Varicose ulcer

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 12 Jan 2011 No development reported - Phase-II for Chronic wounds in Canada (Topical)
  • 05 Jan 2011 Nitric Bio is now called NB Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top